APA

Acocella G., Nonis A., Perna G., Patane E., Gialdroni-Grassi G. & Grassi C. (19890126). Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration study. : The American review of respiratory disease.

Chicago

Acocella G, Nonis A, Perna G, Patane E, Gialdroni-Grassi G and Grassi C. 19890126. Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration study. : The American review of respiratory disease.

Harvard

Acocella G., Nonis A., Perna G., Patane E., Gialdroni-Grassi G. and Grassi C. (19890126). Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration study. : The American review of respiratory disease.

MLA

Acocella G, Nonis A, Perna G, Patane E, Gialdroni-Grassi G and Grassi C. Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration study. : The American review of respiratory disease. 19890126.